WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced U.S. Food and Drug Administration approval and market launch of the Epic Vascular Self-Expanding Stent System.
The company noted that the Epic Stent is designed to open blocked arteries in patients with iliac artery stenosis, a form of peripheral vascular disease associated with severe leg pain caused by insufficient blood flow.
The company said that the Epic Stent employs distal and proximal radiopaque markers and all stent sizes are compatible with 6F sheaths. The stent delivery system is offered in two shaft lengths (75 cm and 120 cm) for all sizes and is compatible with 0.035' guidewires.
The Epic Vascular Self-Expanding Stent System received CE Mark approval and was launched in Europe and other international markets in 2009.
Copyright RTT News/dpa-AFX